...

首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Primary tumor maxSUV by F-18-FDG PET/CT after neoadjuvant chemotherapy as predictive value for the pathologic response in locally advanced breast cancer

【24h】

Primary tumor maxSUV by F-18-FDG PET/CT after neoadjuvant chemotherapy as predictive value for the pathologic response in locally advanced breast cancer

机译：新辅助化疗后通过F-18-FDG PET / CT进行的原发性肿瘤maxSUV对局部晚期乳腺癌的病理反应具有预测价值

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2016年第2期|共2页
作者
Kang S. H.; Kwon S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Primary tumor maxSUV by F-18-FDG PET/CT after neoadjuvant chemotherapy as predictive value for the pathologic response in locally advanced breast cancer [J] . Kang S. H., Kwon S. European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Suppla2期

机译：新辅助化疗后通过F-18-FDG PET / CT进行的原发性肿瘤maxSUV对局部晚期乳腺癌的病理反应具有预测价值
2. Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer [J] . Lori F. Gentile, George Plitas, Emily C. Zabor, Annals of surgical oncology . 2017,第13期

机译：肿瘤生物学预测患有局部晚期乳腺癌的患者对Neoadjuvant化疗的病理完全反应
3. Clinical and Pathological Response to Neoadjuvant Chemotherapy Based on Primary Tumor Reduction is Correlated to Survival in Hormone Receptor-Positive but not Hormone Receptor-Negative Locally Advanced Breast Cancer [J] . Chen Sheng, Liu Yin, Ouyang Qian-Wen, Annals of surgical oncology . 2015,第1期

机译：基于原发性肿瘤减少的新辅助化疗的临床和病理反应与激素受体阳性而非激素受体阴性的局部晚期乳腺癌的存活率相关
4. Functional Imaging of Neoadjuvant Chemotherapy Response in Women with Locally Advanced Breast Cancer using Diffuse Optical Spectroscopy [C] . Hany Soliman, Martin J. Yaffe, Gregory J. Czarnota Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2009

机译：弥漫光学光谱学局部晚期乳腺癌女性新辅助化疗反应的功能成像
5. Using Preoperative Mri-guided Biopsies to Predict Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer [D] . Kim, Jiyoon. 2019

机译：在乳腺癌新辅助化疗后使用术前Mri引导的活检来预测病理完全缓解
6. Tumor biology predicts pathologic complete response to neoadjuvant chemotherapy in patients presenting with locally advanced breast cancer [O] . Lori F. Gentile, George Plitas, Emily C. Zabor, -1

机译：肿瘤生物学预测患有局部晚期乳腺癌的患者对新辅助化疗的病理完全反应
7. Pathological predictive factors for tumor response in locally advanced breast carcinomas treated with anthracyclin-based neoadjuvant chemotherapy [O] . Trupti Patel, Anuja Gupta, Manoj Shah 2013

机译：蒽环类新辅助化疗治疗局部晚期乳腺癌肿瘤反应的病理预测因素
8. P53 Mutation Analysis to Predict Tumor Response in Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer [R] . Carey, L. A. , Dorsey, K. C. , Dressler, L. , 2006

机译：p53突变分析预测局部晚期乳腺癌新辅助治疗患者的肿瘤反应

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号